Giessen, Germany

Hossein Ardeschir Ghofrani

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Nycomed Gmbh. Active years: 2010-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hossein Ardeschir Ghofrani. Retrieved from https://idiyas.com/inventor/hossein-ardeschir-ghofrani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hossein Ardeschir Ghofrani: Innovator in PDE5 Inhibitors

Introduction

Hossein Ardeschir Ghofrani is a notable inventor based in Giessen, Germany. He has made significant contributions to the field of medicine, particularly through his work on PDE5 inhibitors. With a total of 2 patents, Ghofrani's innovations have the potential to impact therapeutic practices.

Latest Patents

Ghofrani's latest patents focus on the use of PDE5 inhibitors in medicine. These inventions aim to enhance the efficacy of treatments involving these compounds, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Ghofrani has worked with prominent companies such as Nycomed GmbH and Takeda GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Ghofrani has collaborated with esteemed colleagues, including Torsten Dunkern and Christian Schudt. These partnerships have contributed to the success of his projects and the advancement of research in his field.

Conclusion

Hossein Ardeschir Ghofrani's work in PDE5 inhibitors exemplifies the impact of innovation in medicine. His contributions continue to shape the landscape of therapeutic options available today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…